Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
Crossref DOI link: https://doi.org/10.1007/s12032-017-0928-z
Published Online: 2017-03-25
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buda-Nowak, Anna
Kucharz, Jakub
Dumnicka, Paulina
Kuzniewski, Marek
Herman, Roman Maria
Zygulska, Aneta L.
Kusnierz-Cabala, Beata
License valid from 2017-03-25